-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
RSV-IN-4
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/862825-89-6.gif)
| Category | Influenza Virus |
| CAS | 862825-89-6 |
| Description | RSV-IN-4 (Compound 2) is a dual inhibitor of respiratory syncytial virus (RSV) and influenza virus A (IAV). RSV-IN-4 shows anti-RSV activity (EC50 = 11.76 μM). |
Product Information
| Synonyms | RSV-IN-4|2-((1H-indol-3-yl)thio)-N-(2-ethoxyphenyl)acetamide|862825-89-6|CHEMBL4746686|N-(2-ethoxyphenyl)-2-(1H-indol-3-ylsulfanyl)acetamide|ZINC4108480|AKOS024587856|HY-143496|CS-0459566|F0616-0359 |
| Molecular Weight | 326.41 |
| Molecular Formula | C18H18N2O2S |
| Canonical SMILES | CCOC1=CC=CC=C1NC(=O)CSC2=CNC3=CC=CC=C32 |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 393 |
| Exact Mass | 326.10889899 |
| In Vitro | RSV-IN-4 (compound 2) (50 µM)shows the inhibition of 83.24% for RSV in a fluorescence-based assay with little or no toxicity to HEp-2 cells. |
| Target | RSV; Influenza Virus |
| XLogP3-AA | 3.4 |
